• Amphetamine, Urine
  • Prosigna Breast Cancer Prognostic Gene Signature
  • 5-Hydroxyindoleacetic Acid (5-HIAA), Urine
  • Aortic Dysfunction or Dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome) Gene Mutation Panel, NGS
  • Alpha Globin (HBA1 and HBA2) Gene Analysis
  • Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) Genotyping
  • Calcium, Ionized
  • Glucose, Random, Urine
  • Interleukin 28 B (IL28B) Gene Variation Analysis
  • Dopamine beta-hydroxylase (DBH) Genetic Variations
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Overview
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.